Markel Co. (NYSE:MKL) insider Nora N. Crouch sold 90 shares of the stock in a transaction dated Tuesday, May 22nd. The shares were sold at an average price of $1,151.58, for a total value of $103,642.20. Following the completion of the transaction, the insider now directly owns 2,577 shares in the company, valued at $2,967,621.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of MKL opened at $1,134.68 on Friday. Markel Co. has a 52 week low of $949.72 and a 52 week high of $1,194.98. The company has a current ratio of 0.59, a quick ratio of 0.59 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $15.86 billion, a PE ratio of 124.74 and a beta of 0.89.
Several institutional investors and hedge funds have recently modified their holdings of the company. Summit Trail Advisors LLC boosted its stake in shares of Markel by 115,809.3% in the first quarter. Summit Trail Advisors LLC now owns 224,864 shares of the insurance provider’s stock worth $225,000 after buying an additional 224,670 shares during the last quarter. WINTON GROUP Ltd boosted its stake in shares of Markel by 166.0% in the first quarter. WINTON GROUP Ltd now owns 1,003 shares of the insurance provider’s stock worth $1,174,000 after buying an additional 626 shares during the last quarter. Rational Advisors LLC purchased a new stake in shares of Markel in the first quarter worth about $1,324,000. CIBC World Markets Inc. boosted its stake in shares of Markel by 48.8% in the first quarter. CIBC World Markets Inc. now owns 8,056 shares of the insurance provider’s stock worth $9,428,000 after buying an additional 2,642 shares during the last quarter. Finally, Xact Kapitalforvaltning AB boosted its stake in shares of Markel by 7.9% in the first quarter. Xact Kapitalforvaltning AB now owns 1,428 shares of the insurance provider’s stock worth $1,671,000 after buying an additional 105 shares during the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.
MKL has been the topic of a number of research reports. William Blair raised Markel from a “market perform” rating to an “outperform” rating in a report on Monday, March 19th. ValuEngine lowered Markel from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Zacks Investment Research raised Markel from a “hold” rating to a “buy” rating and set a $1,287.00 price objective on the stock in a report on Wednesday, April 11th. Argus initiated coverage on Markel in a report on Wednesday, April 11th. They issued a “hold” rating on the stock. Finally, Royal Bank of Canada reissued a “hold” rating and issued a $1,200.00 price objective on shares of Markel in a report on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $1,237.50.
Markel Company Profile
Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.